Globus Pallidus is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The globus pallidus (Latin: "pale globe") is a subcortical structure of the [basal ganglia[/brain-regions/basal-ganglia that serves as the primary output nucleus for motor information processed by the [striatum[/brain-regions/striatum. Located medial to the [putamen[/cell-types/putamen and lateral to the internal capsule, it consists of two functionally distinct segments: the globus pallidus externus (GPe, or lateral segment) and the globus pallidus internus (GPi, or medial segment).
The GPi, together with the [substantia nigra[/brain-regions/substantia-nigra pars reticulata (SNr), provides the final basal ganglia output to the [thalamus[/brain-regions/thalamus and [brainstem[/brain-regions/brainstem, tonically inhibiting thalamo-cortical activity through GABAergic projections.[1]
The globus pallidus is clinically significant in multiple neurodegenerative diseases and is a major therapeutic target for [deep brain stimulation[/treatments/deep-brain-stimulation (DBS). GPi-DBS is a well-established treatment for [Parkinson's disease[/diseases/parkinsons motor complications, dystonia, and [Huntington's disease[/mechanisms/huntington-pathway chorea.
Pathological changes in the globus pallidus occur in Parkinson's Disease, Huntington's Disease, [progressive supranuclear palsy[/diseases/psp, neurodegeneration with brain iron accumulation (NBIA), Wilson's Disease, and other basal ganglia disorders.[2]
The globus pallidus is divided into two segments by the internal (medial) medullary lamina:
Globus Pallidus Externus (GPe):
- Receives inhibitory GABAergic input from D2-expressing [medium spiny neurons[/cell-types/medium-spiny-neurons of the [striatum[/brain-regions/striatum (indirect pathway)
- Projects to the [subthalamic nucleus[/cell-types/subthalamic-nucleus (STN), forming the critical GPe–STN reciprocal circuit
- Also sends projections back to the striatum (pallidostriatal pathway) and directly to GPi (bridging collaterals)
- Contains two main neuron populations: prototypic [neurons[/entities/neurons (projecting to STN, ~70% of GPe [neurons[/entities/neurons and arkypallidal [neurons[/entities/neurons (projecting back to striatum, ~30% of GPe neurons) — a distinction revealed by single-cell transcriptomics and optogenetic mapping[3]
- Functions as a central "hub" of the basal ganglia, integrating and processing information within the indirect pathway
Globus Pallidus Internus (GPi):
- The primary output nucleus of the basal ganglia (along with SNr)
- Receives excitatory glutamatergic input from the STN (indirect/hyperdirect pathways) and inhibitory GABAergic input from D1-expressing [medium spiny neurons[/cell-types/medium-spiny-neurons (direct pathway)
- Projects to the ventrolateral (VL) and ventral anterior (VA) nuclei of the [thalamus[/brain-regions/thalamus, which relay motor information to the [motor cortex[/brain-regions/motor-cortex and premotor [cortex[/brain-regions/cortex
- Also projects to the [pedunculopontine nucleus[/brain-regions/pedunculopontine-nucleus (PPN) in the [brainstem[/brain-regions/brainstem, influencing locomotion and posture
- GPi [neurons[/entities/neurons fire tonically at high rates (~70–80 Hz), providing constant inhibition of thalamic relay [neurons[/entities/neurons. Movement occurs when GPi inhibition is transiently paused by direct pathway input
Globus pallidus neurons are large, multipolar GABAergic neurons with extensive dendritic arbors. Key features:
- High firing rate: GPi neurons fire tonically at 60–80 Hz (GPe at 40–60 Hz), among the highest baseline rates in the brain
- Parvalbumin expression: Most pallidal [neurons[/entities/neurons express parvalbumin and fire in fast, regular patterns
- Myelinated appearance: The pale color of the globus pallidus (giving it its name) results from the dense myelinated fibers passing through it, contributed by both afferent and efferent projections
- High metabolic demand: The continuous high-frequency firing of pallidal neurons requires substantial mitochondrial ATP production, making these cells susceptible to [mitochondrial dysfunction[/mechanisms/mitochondrial-dysfunction and [oxidative stress[/mechanisms/oxidative-stress
- Iron content: The globus pallidus has the highest physiological iron concentration of any brain structure, which increases with aging and is relevant to NBIA disorders[4]
The globus pallidus receives its blood supply from the anterior choroidal artery and lenticulostriate arteries (branches of the middle cerebral artery). This vascular territory is susceptible to:
- Carbon monoxide poisoning (bilateral pallidal necrosis)
- Kernicterus (bilirubin-mediated pallidal damage)
- Hepatic failure (manganese deposition producing T1-hyperintense signal)
The globus pallidus integrates the output of the direct, indirect, and hyperdirect pathways:[5]
- Direct pathway (striatum → GPi): D1-MSNs inhibit GPi, reducing thalamic inhibition, facilitating movement
- Indirect pathway (striatum → GPe → STN → GPi): D2-MSNs inhibit GPe, disinhibiting STN, which excites GPi, increasing thalamic inhibition, suppressing movement
- Hyperdirect pathway ([cortex[/brain-regions/cortex → STN → GPi): Cortical projections directly excite STN, rapidly increasing GPi output to suppress competing motor programs — a "braking" mechanism
In normal function, the dynamic interplay between these pathways allows for the precise selection and execution of desired movements while suppressing unwanted ones.
Recent research has revealed that the GPe is not merely a relay within the indirect pathway but functions as an autonomous pacemaker and integrator:[3]
- GPe neurons exhibit intrinsic oscillatory activity and can generate beta-frequency oscillations (13–30 Hz) that become pathologically enhanced in [Parkinson's disease[/diseases/parkinsons
- The GPe–STN reciprocal circuit is a critical node for generating and propagating pathological oscillations that underlie parkinsonian motor symptoms
- Prototypic GPe neurons provide patterned inhibition to STN that shapes motor output, while arkypallidal neurons project back to striatum to modulate input
- Disruption of the GPe prototypic/arkypallidal balance is implicated in the pathological oscillations characteristic of PD
Beyond motor control, the globus pallidus participates in:
- Cognitive circuits: The associative territory of GPi (receiving from caudate via direct pathway) processes cognitive information relevant to decision-making and habit formation
- Limbic circuits: The ventral pallidum (below the anterior commissure) processes reward and motivational information from the [nucleus accumbens[/cell-types/nucleus-accumbens
- Sleep regulation: Pallidal GABAergic output influences sleep-wake transitions via thalamic and brainstem projections
- Pain processing: The GPi receives nociceptive input and pallidal DBS can modulate pain perception in chronic pain syndromes
In [Parkinson's disease[/diseases/parkinsons, [dopamine[/entities/dopamine depletion in the [putamen[/cell-types/putamen causes a cascade of changes in pallidal activity:[5]
- GPe: Hypoactive due to increased D2-MSN inhibition (indirect pathway overactivation). Reduced GPe activity leads to STN disinhibition
- GPi: Hyperactive due to increased STN excitation and reduced D1-MSN inhibition (direct pathway underactivation). Elevated GPi firing rates cause excessive inhibition of thalamo-cortical circuits, producing akinesia/bradykinesia
- Pathological oscillations: Loss of dopaminergic modulation leads to exaggerated beta-band (13-30 Hz) synchronization in the GPe-STN-GPi circuit, which correlates with movement slowness and can be recorded from DBS electrodes
This pathological shift in pallidal activity, formalized in the Albin-DeLong model, provides the rationale for therapeutic interventions:
- GPi-DBS: High-frequency stimulation of GPi disrupts pathological firing patterns, reducing motor symptoms. GPi-DBS is particularly effective for reducing dyskinesia and medication-related motor fluctuations in advanced PD.
A 2023 multicenter retrospective study confirmed comparable efficacy between GPi-DBS and STN-DBS, with GPi-DBS showing advantages in suppression of dyskinesias, ease of programming, long-term medication flexibility, and safety in patients with mild cognitive decline or depression[6]
- GPi-DBS mechanism: A 2025 study using diffusion tensor imaging demonstrated that GPi-DBS effects propagate along physiological white matter pathways to the thalamus and subthalamic nucleus, confirming that stimulation modulates entire basal ganglia-thalamocortical circuits rather than simply lesioning the GPi[7]
- Pallidotomy: Surgical lesioning of GPi was the treatment of choice before DBS and remains an option when DBS is not available or affordable
The globus pallidus shows significant pathology in [Huntington's disease[/mechanisms/huntington-pathway:[8]
- Chorea mechanism: Early preferential loss of indirect pathway (D2) [medium spiny neurons[/cell-types/medium-spiny-neurons in the [striatum[/brain-regions/striatum reduces GPe inhibition, which in turn reduces STN activity and GPi output, causing the hyperkinetic chorea characteristic of early HD. As the disease progresses, both D1 and D2 MSNs are lost, leading to a mixed hyperkinetic-hypokinetic phenotype
- Pallidal atrophy: MRI volumetrics show pallidal atrophy beginning approximately 3 years before estimated motor onset in premanifest HD gene carriers, making it a potential predictive biomarker
- GPi-DBS for HD chorea: [Deep brain stimulation[/treatments/deep-brain-stimulation of GPi has shown promising results for managing severe, medication-refractory chorea, with sustained benefit at 4+ years follow-up. However, DBS does not slow the underlying neurodegeneration and cognitive decline continues
- [Huntingtin protein[/proteins/htt-protein aggregates: Mutant [huntingtin[/proteins/huntingtin inclusions are found in pallidal neurons, contributing to cell dysfunction and death
In [PSP[/diseases/psp, both GPi and GPe show tau] pathology — neurofibrillary tangles, tufted [astrocytes[/cell-types/astrocytes, and neuropil threads. Pallidal tau] pathology contributes to the axial rigidity, postural instability, and falls that characterize PSP.
Unlike PD, where pallidal dysfunction results from dopamine depletion, PSP involves direct neuronal loss within the pallidum itself, making the pathophysiology fundamentally different and limiting the efficacy of levodopa therapy.[9]
The globus pallidus is the primary site of iron accumulation in NBIA disorders:[10]
- PKAN (pantothenate kinase-associated neurodegeneration): Bilateral iron deposition in GPi produces the pathognomonic "eye of the tiger" sign on T2-weighted MRI — a central hyperintensity (gliosis/vacuolation) surrounded by hypointensity (iron deposition) in the GPi. Caused by mutations in the PANK2 gene, which encodes an enzyme essential for coenzyme A biosynthesis
- PLAN (PLA2G6-associated neurodegeneration): Pallidal iron deposition with progressive dystonia and cognitive decline
- MPAN (mitochondrial membrane protein-associated neurodegeneration): C19orf12 mutations with pallidal iron and optic atrophy
- BPAN (beta-propeller protein-associated neurodegeneration): WDR45 mutations with distinctive childhood static encephalopathy followed by adult-onset parkinsonism-dystonia
- Neuroferritinopathy: FTL (ferritin light chain) mutations with progressive pallidal cavitation
- Aceruloplasminemia: Ceruloplasmin deficiency causing systemic iron overload including severe pallidal deposition
In Wilson's Disease (hepatolenticular degeneration), copper deposition in the globus pallidus and [putamen[/cell-types/putamen causes the characteristic "face of the giant panda" sign on T2-weighted MRI (hyperintensity in the tegmentum with hypointense superior colliculi and preserved red nuclei). Pallidal copper deposition contributes to dystonia and parkinsonian features. Copper chelation therapy (penicillamine, trientine) and zinc supplementation can reverse some pallidal changes if initiated early.
In [corticobasal degeneration[/diseases/corticobasal-degeneration, the globus pallidus shows asymmetric tau] pathology (astrocytic plaques and ballooned neurons) that correlates with the asymmetric limb rigidity and alien limb phenomena characteristic of this disorder.
Chronic manganese exposure (welding, mining, parenteral nutrition) causes selective pallidal toxicity, producing a parkinsonian syndrome with prominent dystonia. T1-weighted MRI shows bilateral pallidal hyperintensity (due to manganese's paramagnetic properties) — a distinctive pattern that distinguishes manganism from idiopathic PD.
The globus pallidus has distinctive imaging characteristics:[4]
- T2-weighted MRI: Normally appears hypointense (dark) due to physiological iron deposition that increases with age. Abnormal signal patterns (hyperintensity, the "eye of the tiger") indicate pathological iron deposition or gliosis
- T1-weighted MRI: Normally isointense; hyperintensity suggests manganese deposition (hepatic encephalopathy, manganism) or calcification
- Quantitative susceptibility mapping (QSM): Quantifies pallidal iron content with high precision; useful for monitoring NBIA disorders, tracking normal aging, and assessing [ferroptosis[/mechanisms/ferroptosis-related neurodegeneration
- [PET imaging[/diagnostics/pet-imaging: GABA-A receptor PET (11C-flumazenil) can quantify pallidal neuronal loss; 18F-FDG PET reveals altered pallidal metabolism in movement disorders. Dopamine D2 receptor PET (11C-raclopride) shows altered pallidal receptor binding in dystonia
- Functional MRI: Task-based and resting-state fMRI reveal pallidal activation during motor planning, action selection, and reward-based decision making
- DBS electrode imaging: Post-operative CT or MRI verification of DBS lead placement in GPi is critical for optimizing stimulation parameters and clinical outcomes
This section links to atlas resources relevant to this brain region.
The study of Globus Pallidus has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
- [Parent A, Bhatt M, 2020 - The Globus Pallidus, Handbook of Clinical Neurology]https://doi.org/10.1016/B978-0-12-820480-1.00078-6)
- [Vitek JL, et al., 2012 - Randomized trial of pallidotomy versus medical therapy for Parkinson's Disease]https://doi.org/10.1002/ana.23594)
- [Abdi A, et al., 2015 - Prototypic and arkypallidal neurons in the dopamine-intact external globus pallidus]https://doi.org/10.1523/JNEUROSCI.4662-14.2015)
- [Hallgren B, Sourander P, 1958 - The effect of age on the non-haemin iron in the human brain]https://doi.org/10.1111/j.1471-4159.1958.tb12607.x)
- [DeLong MR, 1990 - Primate models of movement disorders of basal ganglia origin]https://doi.org/10.1016/S0166-2236(05]80004-7)
- [Mulcahy G, et al., 2023 - GPi deep brain stimulation in Parkinson's Disease: multicenter retrospective study]https://pmc.ncbi.nlm.nih.gov/articles/PMC10761504/)
- [GPi-DBS travels to thalamus and STN along physiological pathways, Frontiers in Neuroscience, 2025]https://doi.org/10.3389/fnins.2025.1592689)
- [Gonzalez V, et al., 2014 - Deep brain stimulation for Huntington's Disease: long-term results of a prospective open-label study]https://doi.org/10.1007/s00415-015-7968-0)
- [Williams DR, Lees AJ, 2009 - Progressive Supranuclear Palsy: clinicopathological concepts and diagnostic challenges]https://doi.org/10.1016/S1474-4422(09]70042-0)
- [Hayflick SJ, et al., 2003 - Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome]https://doi.org/10.1056/NEJMoa020817)
- [Aylward EH, et al., 2011 - Striatal and pallidal volume in preclinical Huntington's Disease]https://doi.org/10.1093/brain/awr075)
- [Helmich RC, et al., 2021 - GPi-DBS for movement disorders: current evidence and future directions]https://doi.org/10.1007/s40120-020-00220-5)
-
-
-
-